Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

32.70
Delayed Data
As of Feb 08
 -1.06 / -3.14%
Today’s Change
31.83
Today|||52-Week Range
52.10
-23.53%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 48.00, with a high estimate of 60.00 and a low estimate of 34.00. The median estimate represents a +46.79% increase from the last price of 32.70.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Impax Laboratories Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.43
Sales
$222.3M
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.71%
 
 
 
 
 
 
Growthannually -3.94%
 
 
 
 
 
 

Sales

Growthquarterly 0.52%
 
 
 
 
 
 
Growthannually 34.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.